10% off all books and free delivery over £40 - Last Express Posting Date for Christmas: 20th December
Buy from our bookstore and 25% of the cover price will be given to a school of your choice to buy more books. *15% of eBooks.

Dose Finding in Drug Development

View All Editions

The selected edition of this book is not available to buy right now.
Add To Wishlist
Write A Review

About

Dose Finding in Drug Development Synopsis

This book emphasizes dose selection issues from a statistical point of view. It presentsstatisticalapplicationsinthedesignandanalysisofdose-responsestudies. The importance of this subject can be found from the International Conference on Harmonization (ICH) E4 Guidance document. Establishing the dose-response relationship is one of the most important act- ities in developing a new drug. A clinical development program for a new drug can be broadly divided into four phases - namely Phases I, II, III, and IV. Phase I clinical trials are designed to study the clinical pharmacology. Information - tained from these studies will help in designing Phase II studies. Dose-response relationshipsareusuallystudiedinPhaseII.PhaseIIIclinicaltrialsarelarge-scale, long-term studies. These studies serve to con?rm ?ndings from Phases I and II. ResultsobtainedfromPhasesI,II,andIIIclinicaltrialswouldthenbedocumented and submitted to regulatory agencies for drug approval. In the United States, - viewers from Food and Drug Administration (FDA) review these documents and make a decision to approve or to reject this New Drug Application (NDA). If the new drug is approved, then Phase IV studies can be started. Phase IV clinical trials are also known as postmarketing studies.

About This Edition

ISBN: 9780387290744
Publication date: 7th March 2006
Author: Naitee Ting
Publisher: Springer an imprint of Springer New York
Format: Hardback
Pagination: 248 pages
Series: Statistics for Biology and Health
Genres: Pharmacology
Probability and statistics